Fast tracking drugs to patients: Drug approval agencies are frequently criticised for either being too slow or too fast

AUTOR(ES)

Brower, Vicki

FONTE

Oxford University Press

Documentos Relacionados

• FDA's counsel accused of being too close to drug industry
• Are Canadians paying too much for generic drugs?
• Prescription drug expenditures rising — too fast?
• Chondroprotective agents: are we being too dogmatic?
• Fast or slow pathway ablation (or neither) for AV nodal tachycardia?